Top Midday Gainers

MT Newswires Live02-07

Pulse Biosciences (PLSE) shares climbed past 33% after midday Friday following the company's late Thursday announcement that clinical data from its nPulse cardiac catheter feasibility study showed successful treatment of atrial fibrillation in 150 patients with "rapid" procedure times and minimal adverse effects.

More than 1.6 million shares traded intraday compared with a daily average of about 184,000.

BILL (BILL) has been in talks to be acquired by Hellman & Friedman, Bloomberg reported Friday, citing people familiar with the matter. BILL didn't immediately reply to a request for comment from MT Newswires.

Its shares rose 40% as intraday trading volume soared to 12 million from a daily average of roughly 2.6 million.

Envista (NVST) shares were up 16% amid heavy trading after the company reported late Thursday a stronger-than-expected jump in Q4 adjusted earnings and sales.

Over 6 million shares traded intraday versus a daily average of nearly 2.4 million.

Price: 18.31, Change: +4.62, Percent Change: +33.75

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2609286515?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-07 02:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609286515","market":"sg","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/PLSE\">Pulse Biosciences</a> (PLSE) shares climbed past 33% after midday Friday following the company's late Thursday announcement that clinical data from its nPulse cardiac catheter feasibility study showed successful treatment of atrial fibrillation in 150 patients with \"rapid\" procedure times and minimal adverse effects.</p><p>More than 1.6 million shares traded intraday compared with a daily average of about 184,000.</p><p>BILL (BILL) has been in talks to be acquired by Hellman &amp; Friedman, Bloomberg reported Friday, citing people familiar with the matter. BILL didn't immediately reply to a request for comment from MT Newswires.</p><p>Its shares rose 40% as intraday trading volume soared to 12 million from a daily average of roughly 2.6 million.</p><p>Envista (NVST) shares were up 16% amid heavy trading after the company reported late Thursday a stronger-than-expected jump in Q4 adjusted earnings and sales.</p><p>Over 6 million shares traded intraday versus a daily average of nearly 2.4 million.</p><p>Price: 18.31, Change: +4.62, Percent Change: +33.75</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-02-07 02:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/PLSE\">Pulse Biosciences</a> (PLSE) shares climbed past 33% after midday Friday following the company's late Thursday announcement that clinical data from its nPulse cardiac catheter feasibility study showed successful treatment of atrial fibrillation in 150 patients with \"rapid\" procedure times and minimal adverse effects.</p><p>More than 1.6 million shares traded intraday compared with a daily average of about 184,000.</p><p>BILL (BILL) has been in talks to be acquired by Hellman &amp; Friedman, Bloomberg reported Friday, citing people familiar with the matter. BILL didn't immediately reply to a request for comment from MT Newswires.</p><p>Its shares rose 40% as intraday trading volume soared to 12 million from a daily average of roughly 2.6 million.</p><p>Envista (NVST) shares were up 16% amid heavy trading after the company reported late Thursday a stronger-than-expected jump in Q4 adjusted earnings and sales.</p><p>Over 6 million shares traded intraday versus a daily average of nearly 2.4 million.</p><p>Price: 18.31, Change: +4.62, Percent Change: +33.75</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0477156797.USD","symbol_name":"HARRIS ASSOCIATES GLOBAL EQUITY \"RE\" (USD) ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2609286515","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2609286515","pubTimestamp":1770404055,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Pulse Biosciences  shares climbed past 33% after midday Friday following the company's late Thursday announcement that clinical data from its nPulse cardiac catheter feasibility study showed successful treatment of atrial fibrillation in 150 patients with \"rapid\" procedure times and minimal adverse effects.More than 1.6 million shares traded intraday compared with a daily average of about 184,000.BILL  has been in talks to be acquired by Hellman & Friedman, Bloomberg reported Friday, citing people familiar with the matter. BILL didn't immediately reply to a request for comment from MT Newswires.Its shares rose 40% as intraday trading volume soared to 12 million from a daily average of roughly 2.6 million.Envista  shares were up 16% amid heavy trading after the company reported late Thursday a stronger-than-expected jump in Q4 adjusted earnings and sales.Over 6 million shares traded intraday versus a daily average of nearly 2.4 million.Price: 18.31, Change: +4.62, Percent Change: +33.75","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0477156797.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"RE\" (USD) ACC","LU0130518102.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"R\" INC","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","BK4551":"寇图资本持仓","NVST":"Envista Holdings","BILL":"BILL HOLDINGS INC","PLSE":"Pulse Biosciences, Inc.","BK4588":"碎股","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","BK4023":"应用软件","BILL.AU":"ISHARES CORE CASH ETF","BK4585":"ETF&股票定投概念","BK4535":"淡马锡持仓","BK4082":"医疗保健设备","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BILL.AU":1,"PLSE":1,"NVST":1,"BILL":1},"content_text":"Pulse Biosciences (PLSE) shares climbed past 33% after midday Friday following the company's late Thursday announcement that clinical data from its nPulse cardiac catheter feasibility study showed successful treatment of atrial fibrillation in 150 patients with \"rapid\" procedure times and minimal adverse effects.More than 1.6 million shares traded intraday compared with a daily average of about 184,000.BILL (BILL) has been in talks to be acquired by Hellman & Friedman, Bloomberg reported Friday, citing people familiar with the matter. BILL didn't immediately reply to a request for comment from MT Newswires.Its shares rose 40% as intraday trading volume soared to 12 million from a daily average of roughly 2.6 million.Envista (NVST) shares were up 16% amid heavy trading after the company reported late Thursday a stronger-than-expected jump in Q4 adjusted earnings and sales.Over 6 million shares traded intraday versus a daily average of nearly 2.4 million.Price: 18.31, Change: +4.62, Percent Change: +33.75","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2609286515","isCrawlerRequest":true}